MARKET

BIFRF

BIFRF

Biofrontera
OTCID
2.600
NaN%
Closed 09:30 06/23 EDT
OPEN
--
PREV CLOSE
2.600
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
3.250
52 WEEK LOW
2.600
MARKET CAP
15.80M
P/E (TTM)
42.55
1D
5D
1M
3M
1Y
5Y
1D
No Data
About BIFRF
Biofrontera AG is a Germany-based biopharmaceutical company. The Company develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and warts; PDT lamp BF-RhodoLED, used after the Ameluz treatment to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients for the care of itching, inflamed and flaky skin and conditions such as insect bites, burns, neurodermatitis and psoriasis. The Company is also engaged in clinical development of two drug candidates: BF-derm1, a tablet with inhibitor blocking the synthesis of histamine in cells, a cause of allergic reactions; and BF1, a selective serotonin receptor to prevent migraines. The Company operates five wholly owned subsidiaries, notably Biofrontera Inc in the United States. Its main shareholder is MM Familien KG.

Webull offers Biofrontera AG stock information, including OTCID: BIFRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIFRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIFRF stock methods without spending real money on the virtual paper trading platform.